Low-Dose Irradiation and Short-Exposure Suboptimal-Dose Paclitaxel Adversely Modulate Metastatic Potential of Squamous Carcinoma Cells

Strahlentherapie und Onkologie

Volumn 179, Issue 12, 2003, Pages 812-818

  Lövey, József ^a   Fazekas, Károly ^a   Ladányi, Andrea ^a   Németh, György ^a   Tímár, József ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Low dose irradiation; Metastasis; Paclitaxel; Proliferation

Indexed keywords

PACLITAXEL; RADIOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DRUG EXPOSURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERPHASE; LIVER METASTASIS; METASTASIS; METASTASIS INHIBITION; MICROTUBULE; MOUSE; NONHUMAN; RADIATION DOSE; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; CYTOSKELETON; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERPHASE; LIVER NEOPLASMS; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 0345530021     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1051-y     Document Type: Article

References (32)

1. Belotti D, Rieppi M, Nicoletti MI, et al. Paclitaxel (Taxol®) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res 1996;2:1725-30.
2. Belotti D, Vergani V, Drudis T, et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996;2:1843-9.
3. Cordes N, Palsswilm L, Sauer R. Interaction of paclitaxel (Taxol) and irradiation. Strahlenther Onkol 1999;175:175-81.
4. Haddad M, Taylor JD. Nonlethal gamma radiation displays similar cytoplasmic rearrengements as 12(s)-HETE. Adv Exp Med Biol 1997;400B:889-94.
5. Hagmann W, Gao X, Timar J, et al. 12-lipoxygenase in A431 cells: genetic identity, modulation of expression and intracellular localization. Exp Cell Res 1996;228:197-205.
6. Hennequin C, Giocanti N, Favaudon N. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res 1996;56:1842-50.
7. Hoffman W, Belkas C, Schmidberger H, et al. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer - results from a phase I trial. Int J Radiat Oncol Biol Phys 1997;38:691-6.
8. Ingram ML, Redpath JL. Subadditive interaction of radiation and Taxol in vitro. Int J Radiat Oncol Biol Phys 1997;37:1139-44.
9. Jain RK. The next frontier of molecular medicine: delivery of therapeutics. Nat Med 1998;4:655-7.
10. Kantak SS, Diglio CA, Onoda JM. Low dose radiation-induced endothelial cell retraction. Int J Radiat Biol 1993;64:319-28.
11. Kortmann RD, Jeremic B, Weller M, et al. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Strahlenther Onkol 2003;179:219-32.
12. Leonard CE, Chan DC, Chou T-C, et al. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res 1996;56:5198-204.
13. Liebmann J, Herscher J, Fischer D, et al. Antagonism of paclitaxel toxicity by X-rays: implications for combined modality therapy. Int J Oncol 1996; 8:991-6.
14. Liebmann JE, Cook JA, Fisher J, et al. In vitro studies of Taxol as a radiation senistizer. J Natl Cancer Inst 1994;86:441-6.
15. Link EM, Flanagan K, Michalowski AS, et al. Low-dose of ionising radiation induce melanoma metastases and trigger the immune system-adrenal axis feedback loop. Eur J Cancer 1999;35:1526-33.
16. Milas L, Hunter NR, Mason KA, et al. Enhancement of tumor radioresponse of a murine mammary carcinoma by Taxol. Cancer Res 1994;54:3506-10.
17. Netti PA, Berk DA, Swartz MA, et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000;60:2497-503.
18. Onoda JM, Kantak SS, Piechocki MP, et al. Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor. Radiat Res 1994;140:410-8.
19. Pradier O, Rave-Frank M, Schmidberger H, et al. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7). J Cancer Res Clin Oncol 1999;125:20-7.
20. Rave-Frank M, Meden H, Jaschke A, et al. The effect of paclitaxel on the radiosensitivity of gynecological tumor cells. Strahlenther Onkol 1997;173: 281-6.
21. Rodel F, Kamprad F, Sauer R, et al. Functional and molecular aspects of antiinflammatory effects of low-dose radiotherapy. Strahlenther Onkol 2002; 178:1-9.
22. Rosenthal DI, Lee JH, Sinard RJ, et al. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 2001;19:1363-73.
23. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubute agent. J Nat[Cancer Inst 1990;82:1247-59.
24. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979;277:665-7.
25. Schuck A, Muller SB, Kohler A, et al. Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma. Strahlenther Onkol 2002; 178:486-90.
26. Sharma RK, Jain V. Radiotherapeutic response of Ehrlich ascites tumor cells perfused in agarose gel threads and implanted in mice. A 31P MR spectroscopy study. Strahlenther Onkol 2001;177:212-9.
27. Srivastava RK, Srivastava AR, Korsmeyer SJ, et al. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 1998;18:3509-17.
28. Timár J, Rásó E, Honn KV, et al. 12-lipoxygenase expression in human melanoma cell lines. Adv Exp Med Biol 1999;469:617-22.
29. Tishler RB, Busse PM, Norris CM, et al. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys 1999;43:1001-8.
30. Tishler RB, Schiff PB, Geard CR, et al. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 1992;22:613-7.
31. Westerlund A, Hujanen E, Hoyhtya M, et al. Ovarian cancer cell invasion is inhibited by paclitaxel. Clin Exp Metastasis 1997;15:318-28.
32. Zhou X, Li J, Kucik DF. The microtubule cytoskeleton participates in control of beta2 integrin avidity. J Biol Chem 2001;276:44762-9.